{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:47:45Z","timestamp":1794008865880,"version":"4.8.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T00:00:00Z","timestamp":1541548800000},"content-version":"vor","delay-in-days":37,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["203105\/Z\/16\/Z"],"award-info":[{"award-number":["203105\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L016354\/1"],"award-info":[{"award-number":["MR\/L016354\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s13311-018-00674-4","type":"journal-article","created":{"date-parts":[[2018,11,7]],"date-time":"2018-11-07T15:04:25Z","timestamp":1541603065000},"page":"943-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Diagnosis and Treatment of Mitochondrial Myopathies"],"prefix":"10.1016","volume":"15","author":[{"given":"Syeda T.","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyndsey","family":"Craven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver M.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug M.","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0360-6644","authenticated-orcid":false,"given":"Amy E.","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-018-00674-4_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.80","article-title":"Mitochondrial diseases","volume":"2","author":"Gorman","year":"2016","journal-title":"Nat Rev Dis Primers"},{"issue":"20","key":"10.1007\/s13311-018-00674-4_bib2","doi-asserted-by":"crossref","first-page":"7952","DOI":"10.1073\/pnas.86.20.7952","article-title":"Spontaneous Kearns-Sayre\/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy","volume":"86","author":"Shoffner","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 3","key":"10.1007\/s13311-018-00674-4_bib3","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1042\/bj20021594","article-title":"Mitochondrial threshold effects","volume":"370","author":"Rossignol","year":"2003","journal-title":"Biochem J"},{"issue":"D1","key":"10.1007\/s13311-018-00674-4_bib4","doi-asserted-by":"crossref","first-page":"D1258","DOI":"10.1093\/nar\/gkv1001","article-title":"MitoMiner v3.1, an update on the mitochondrial proteomics database","volume":"44","author":"Smith","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1007\/s13311-018-00674-4_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JND-140041","article-title":"Adult-onset Mendelian PEO Associated with Mitochondrial Disease","volume":"1","author":"Sommerville","year":"2014","journal-title":"J Neuromuscul Dis"},{"issue":"7","key":"10.1007\/s13311-018-00674-4_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.nmd.2015.03.001","article-title":"Perceived fatigue is highly prevalent and debilitating in patients with mitochondrial disease","volume":"25","author":"Gorman","year":"2015","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1007\/s13311-018-00674-4_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/path.4809","article-title":"The genetics and pathology of mitochondrial disease","volume":"241","author":"Alston","year":"2017","journal-title":"J Pathol"},{"issue":"5","key":"10.1007\/s13311-018-00674-4_bib8","first-page":"934","article-title":"The mitochondrial tRNA(Leu(UUR)) mutation in mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes (MELAS): genetic, biochemical, and morphological correlations in skeletal muscle","volume":"50","author":"Moraes","year":"1992","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1007\/s13311-018-00674-4_bib9","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1086\/507132","article-title":"Mitochondrial DNA\u2013Deletion Mutations Accumulate Intracellularly to Detrimental Levels in Aged Human Skeletal Muscle Fibers","volume":"79","author":"Bua","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"17","key":"10.1007\/s13311-018-00674-4_bib10","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1093\/hmg\/ddu176","article-title":"Dissecting the mechanisms underlying the accumulation of mitochondrial DNA deletions in human skeletal muscle","volume":"23","author":"Campbell","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"16","key":"10.1007\/s13311-018-00674-4_bib11","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1113\/JP271212","article-title":"The ageing neuromuscular system and sarcopenia: a mitochondrial perspective","volume":"594","author":"Rygiel Karolina","year":"2016","journal-title":"J Physiol"},{"issue":"1","key":"10.1007\/s13311-018-00674-4_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14623-2","article-title":"Using a quantitative quadruple immunofluorescent assay to diagnose isolated mitochondrial Complex I deficiency","volume":"7","author":"Ahmed","year":"2017","journal-title":"Sci Rep"},{"key":"10.1007\/s13311-018-00674-4_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep15037","article-title":"A novel immunofluorescent assay to investigate oxidative phosphorylation deficiency in mitochondrial myopathy: understanding mechanisms and improving diagnosis","volume":"5","author":"Rocha","year":"2015","journal-title":"Sci Rep"},{"issue":"9","key":"10.1007\/s13311-018-00674-4_bib14","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1212\/01.WNL.0000033795.17156.00","article-title":"Diagnostic criteria for respiratory chain disorders in adults and children","volume":"59","author":"Bernier","year":"2002","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-018-00674-4_bib15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.2014.7184","article-title":"Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies","volume":"312","author":"Taylor","year":"2014","journal-title":"JAMA"},{"key":"10.1007\/s13311-018-00674-4_bib16","article-title":"Mitochondrial energy generation disorders: genes, mechanisms and clues to pathology","author":"Frazier","year":"2017","journal-title":"J Biol Chem"},{"key":"10.1007\/s13311-018-00674-4_bib17","doi-asserted-by":"crossref","unstructured":"Grady JP, Pickett SJ. mtDNA heteroplasmy level and copy number indicate disease burden in m.3243A>G mitochondrial disease. 10(6) (2018).","DOI":"10.15252\/emmm.201708262"},{"issue":"118","key":"10.1007\/s13311-018-00674-4_bib18","doi-asserted-by":"crossref","first-page":"118ra110","DOI":"10.1126\/scitranslmed.3003310","article-title":"Molecular Diagnosis of Infantile Mitochondrial Disease with Targeted Next-Generation Sequencing","volume":"4","author":"Calvo","year":"2012","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1007\/s13311-018-00674-4_bib19","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/ng1776","article-title":"Systematic identification of human mitochondrial disease genes through integrative genomics","volume":"38","author":"Calvo","year":"2006","journal-title":"Nat Genet"},{"issue":"8","key":"10.1007\/s13311-018-00674-4_bib20","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S1474-4422(10)70116-2","article-title":"A neurological perspective on mitochondrial disease","volume":"9","author":"McFarland","year":"2010","journal-title":"Lancet Neurol"},{"issue":"Pt 2","key":"10.1007\/s13311-018-00674-4_bib21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/brain\/awt321","article-title":"Disease progression in patients with single, large-scale mitochondrial DNA deletions","volume":"137","author":"Grady","year":"2014","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-018-00674-4_bib22","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12306-011-0096-9","article-title":"Metabolic myopathies: functional evaluation by different exercise testing approaches","volume":"95","author":"Volpi","year":"2011","journal-title":"Musculoskelet Surg"},{"issue":"4","key":"10.1007\/s13311-018-00674-4_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/ajmg.a.20449","article-title":"Clinical variability in maternally inherited leber hereditary optic neuropathy with the G14459A mutation","volume":"124a","author":"Tarnopolsky","year":"2004","journal-title":"Am J Med Genet A"},{"issue":"9","key":"10.1007\/s13311-018-00674-4_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/S1474-4422(11)70155-7","article-title":"FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study","volume":"10","author":"Suomalainen","year":"2011","journal-title":"The Lancet, Neurology"},{"issue":"22","key":"10.1007\/s13311-018-00674-4_bib25","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","article-title":"FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders","volume":"87","author":"Lehtonen","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1007\/s13311-018-00674-4_bib26","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/jcm6080080","article-title":"Use of FGF-21 as a Biomarker of Mitochondrial Disease in Clinical Practice","volume":"6","author":"Morovat","year":"2017","journal-title":"J Clin Med"},{"issue":"5","key":"10.1007\/s13311-018-00674-4_bib27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/ana.24506","article-title":"Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders","volume":"78","author":"Yatsuga","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1007\/s13311-018-00674-4_bib28","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mito.2014.10.006","article-title":"GDF15 is a novel biomarker to evaluate efficacy of pyruvate therapy for mitochondrial diseases","volume":"20","author":"Fujita","year":"2015","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1007\/s13311-018-00674-4_bib29","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10027","article-title":"Venous oxygen levels during aerobic forearm exercise: An index of impaired oxidative metabolism in mitochondrial myopathy","volume":"51","author":"Taivassalo","year":"2002","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1007\/s13311-018-00674-4_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/jnnp-2011-301258","article-title":"Adult-onset cerebellar ataxia due to mutations in CABC1\/ADCK3","volume":"83","author":"Horvath","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1007\/s13311-018-00674-4_bib31","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/mus.21758","article-title":"A randomized trial of coenzyme Q10 in mitochondrial disorders","volume":"42","author":"Glover Elisa","year":"2010","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1007\/s13311-018-00674-4_bib32","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.mito.2012.09.005","article-title":"Design and Implementation of the First Randomized Controlled Trial of Coenzyme Q(10) in Children with Primary Mitochondrial Diseases","volume":"12","author":"Stacpoole","year":"2012","journal-title":"Mitochondrion"},{"issue":"2","key":"10.1007\/s13311-018-00674-4_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbabio.2011.10.012","article-title":"The effects of idebenone on mitochondrial bioenergetics","volume":"1817","author":"Giorgio","year":"2012","journal-title":"Biochim Biophys Acta"},{"issue":"Pt 9","key":"10.1007\/s13311-018-00674-4_bib34","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awr170","article-title":"A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy","volume":"134","author":"Klopstock","year":"2011","journal-title":"Brain"},{"key":"10.1007\/s13311-018-00674-4_bib35","author":"Kaufmann"},{"key":"10.1007\/s13311-018-00674-4_bib36","author":"Hirano"},{"issue":"6","key":"10.1007\/s13311-018-00674-4_bib37","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.cmet.2012.04.022","article-title":"The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet induced obesity","volume":"15","author":"Cant\u00f3","year":"2012","journal-title":"Cell Metab"},{"issue":"4","key":"10.1007\/s13311-018-00674-4_bib38","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0092-8674(04)00416-7","article-title":"Discoveries of nicotinamide riboside as a nutrient and conserved NRK genes establish a Preiss-Handler independent route to NAD+ in fungi and humans","volume":"117","author":"Bieganowski","year":"2004","journal-title":"Cell"},{"issue":"6","key":"10.1007\/s13311-018-00674-4_bib39","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/emmm.201403943","article-title":"Effective treatment of mitochondrial myopathy by nicotinamide riboside, a vitamin B3","volume":"6","author":"Khan","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"49","key":"10.1007\/s13311-018-00674-4_bib40","doi-asserted-by":"crossref","first-page":"17687","DOI":"10.1073\/pnas.0505551102","article-title":"Mutant mitochondrial helicase Twinkle causes multiple mtDNA deletions and a late-onset mitochondrial disease in mice","volume":"102","author":"Tyynismaa","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1007\/s13311-018-00674-4_bib41","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2337\/db14-0667","article-title":"Evidence for a direct effect of the NAD+ precursor acipimox on muscle mitochondrial function in humans","volume":"64","author":"van de Weijer","year":"2015","journal-title":"Diabetes"},{"issue":"3","key":"10.1007\/s13311-018-00674-4_bib42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/hmg\/ddr482","article-title":"Effect of bezafibrate treatment on late-onset mitochondrial myopathy in mice","volume":"21","author":"Yatsuga","year":"2012","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1007\/s13311-018-00674-4_bib43","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cmet.2011.04.011","article-title":"In vivo correction of COX deficiency by activation of the AMPK\/PGC-1alpha axis","volume":"14","author":"Viscomi","year":"2011","journal-title":"Cell Metab"},{"issue":"5","key":"10.1007\/s13311-018-00674-4_bib44","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1667\/RR13578.1","article-title":"Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitis","volume":"181","author":"Reisman","year":"2014","journal-title":"Radiat Res"},{"issue":"1","key":"10.1007\/s13311-018-00674-4_bib45","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00125-007-0852-4","article-title":"R-alpha-lipoic acid and acetyl-L-carnitine complementarily promote mitochondrial biogenesis in murine 3T3-L1 adipocytes","volume":"51","author":"Shen","year":"2008","journal-title":"Diabetologia"},{"issue":"10","key":"10.1007\/s13311-018-00674-4_bib46","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1093\/hmg\/ddq076","article-title":"Ketogenic diet slows down mitochondrial myopathy progression in mice","volume":"19","author":"Ahola-Erkkila","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1007\/s13311-018-00674-4_bib47","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/ana.20240","article-title":"Ketogenic treatment reduces deleted mitochondrial DNAs in cultured human cells","volume":"56","author":"Santra","year":"2004","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1007\/s13311-018-00674-4_bib48","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.15252\/emmm.201606592","article-title":"Modified Atkins diet induces subacute selective ragged-red-fiber lysis in mitochondrial myopathy patients","volume":"8","author":"Ahola","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"7","key":"10.1007\/s13311-018-00674-4_bib49","first-page":"701","article-title":"A mitochondrial therapeutic reverses visual decline in mouse models of diabetes","volume":"8","author":"Alam","year":"2015","journal-title":"Dis Model Mech"},{"issue":"6","key":"10.1007\/s13311-018-00674-4_bib50","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/clpt.2014.174","article-title":"Serendipity and the Discovery of Novel Compounds That Restore Mitochondrial Plasticity","volume":"96","author":"Szeto","year":"2014","journal-title":"Clin Pharmacol Ther"},{"issue":"5","key":"10.1007\/s13311-018-00674-4_bib51","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/acel.12102","article-title":"Mitochondrial-targeted peptide rapidly improves mitochondrial energetics and skeletal muscle performance in aged mice","volume":"12","author":"Siegel","year":"2013","journal-title":"Aging Cell"},{"issue":"14","key":"10.1007\/s13311-018-00674-4_bib52","doi-asserted-by":"crossref","first-page":"e1212","DOI":"10.1212\/WNL.0000000000005255","article-title":"Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy","volume":"90","author":"Karaa","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-018-00674-4_bib53","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-017-0715-0","article-title":"KH176 under development for rare mitochondrial disease: a first in man randomized controlled clinical trial in healthy male volunteers","volume":"12","author":"Koene","year":"2017","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"10.1007\/s13311-018-00674-4_bib54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ana.1050","article-title":"Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects","volume":"50","author":"Taivassalo","year":"2001","journal-title":"Ann Neurol"},{"issue":"Pt 12","key":"10.1007\/s13311-018-00674-4_bib55","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1093\/brain\/awl149","article-title":"Aerobic training is safe and improves exercise capacity in patients with mitochondrial myopathy","volume":"129","author":"Jeppesen","year":"2006","journal-title":"Brain"},{"issue":"Pt 12","key":"10.1007\/s13311-018-00674-4_bib56","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1093\/brain\/awl282","article-title":"Endurance training and detraining in mitochondrial myopathies due to single large-scale mtDNA deletions","volume":"129","author":"Taivassalo","year":"2006","journal-title":"Brain"},{"issue":"Pt 2","key":"10.1007\/s13311-018-00674-4_bib57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/brain\/awg028","article-title":"The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients","volume":"126","author":"Taivassalo","year":"2003","journal-title":"Brain"},{"issue":"3","key":"10.1007\/s13311-018-00674-4_bib58","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/mus.20368","article-title":"Exercise training in mitochondrial myopathy: a randomized controlled trial","volume":"32","author":"Cejudo","year":"2005","journal-title":"Muscle Nerve"},{"issue":"Pt 11","key":"10.1007\/s13311-018-00674-4_bib59","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1093\/brain\/awn252","article-title":"Resistance training in patients with single, large-scale deletions of mitochondrial DNA","volume":"131","author":"Murphy","year":"2008","journal-title":"Brain"},{"issue":"4","key":"10.1007\/s13311-018-00674-4_bib60","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1016\/j.ijcard.2013.05.062","article-title":"Defining cardiac adaptations and safety of endurance training in patients with m.3243A>G-related mitochondrial disease","volume":"168","author":"Bates","year":"2013","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1007\/s13311-018-00674-4_bib61","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1093\/brain\/awn264","article-title":"Train, train, train! No pain, just gain","volume":"131","author":"Zeviani","year":"2008","journal-title":"Brain"},{"issue":"12","key":"10.1007\/s13311-018-00674-4_bib62","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1093\/nar\/gkn313","article-title":"Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA","volume":"36","author":"Minczuk","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"10.1007\/s13311-018-00674-4_bib63","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/B978-0-12-801415-8.00018-7","article-title":"The Use of Mitochondria-Targeted Endonucleases to Manipulate mtDNA","volume":"547","author":"Bacman","year":"2014","journal-title":"Methods Enzymol"},{"issue":"4","key":"10.1007\/s13311-018-00674-4_bib64","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/emmm.201303672","article-title":"Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations","volume":"6","author":"Gammage","year":"2014","journal-title":"EMBO Mol Med"},{"issue":"10","key":"10.1007\/s13311-018-00674-4_bib65","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/mt.2015.126","article-title":"MitoTALEN: A General Approach to Reduce Mutant mtDNA Loads and Restore Oxidative Phosphorylation Function in Mitochondrial Diseases","volume":"23","author":"Hashimoto","year":"2015","journal-title":"Mol Ther"},{"issue":"16","key":"10.1007\/s13311-018-00674-4_bib66","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1093\/nar\/gkw676","article-title":"Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs","volume":"44","author":"Gammage","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1007\/s13311-018-00674-4_bib67","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cell.2015.03.051","article-title":"Selective elimination of mitochondrial mutations in the germline by genome editing","volume":"161","author":"Reddy","year":"2015","journal-title":"Cell"},{"issue":"8","key":"10.1007\/s13311-018-00674-4_bib68","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.15252\/emmm.201404092","article-title":"Deoxypyrimidine monophosphate bypass therapy for thymidine kinase 2 deficiency","volume":"6","author":"Garone","year":"2014","journal-title":"EMBO Mol Med"},{"key":"10.1007\/s13311-018-00674-4_bib69","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2014.35","article-title":"A national perspective on prenatal testing for mitochondrial disease","volume":"22","author":"Nesbitt","year":"2014","journal-title":"Eur J Hum Genet"},{"key":"10.1007\/s13311-018-00674-4_bib70","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/nyas.12866","article-title":"Preventing the transmission of mitochondrial DNA disorders using prenatal or preimplantation genetic diagnosis","volume":"1350","author":"Smeets","year":"2015","journal-title":"Ann N Y Acad Sci"},{"issue":"7294","key":"10.1007\/s13311-018-00674-4_bib71","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/nature08958","article-title":"Pronuclear transfer in human embryos to prevent transmission of mitochondrial DNA disease","volume":"465","author":"Craven","year":"2010","journal-title":"Nature"},{"issue":"1","key":"10.1007\/s13311-018-00674-4_bib72","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-genom-091416-035426","article-title":"Recent Advances in Mitochondrial Disease","volume":"18","author":"Lyndsey","year":"2017","journal-title":"Annu Rev Genomics Hum Genet"},{"issue":"6","key":"10.1007\/s13311-018-00674-4_bib73","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.stem.2016.04.001","article-title":"Genetic Drift Can Compromise Mitochondrial Replacement by Nuclear Transfer in Human Oocytes","volume":"18","author":"Yamada","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"7632","key":"10.1007\/s13311-018-00674-4_bib74","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature20592","article-title":"Mitochondrial replacement in human oocytes carrying pathogenic mitochondrial DNA mutations","volume":"540","author":"Kang","year":"2016","journal-title":"Nature"},{"issue":"7607","key":"10.1007\/s13311-018-00674-4_bib75","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nature18303","article-title":"Towards clinical application of pronuclear transfer to prevent mitochondrial DNA disease","volume":"534","author":"Hyslop","year":"2016","journal-title":"Nature"},{"key":"10.1007\/s13311-018-00674-4_bib76","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.3997","article-title":"Assisted reproductive technologies to prevent human mitochondrial disease transmission","volume":"35","author":"Greenfield","year":"2017","journal-title":"Nat Biotechnol"},{"issue":"2","key":"10.1007\/s13311-018-00674-4_bib77","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/stem.2221","article-title":"Research into Policy: A Brief History of Mitochondrial Donation","volume":"34","author":"Craven","year":"2016","journal-title":"Stem Cells"},{"issue":"9","key":"10.1007\/s13311-018-00674-4_bib78","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1500960","article-title":"Mitochondrial donation\u2013how many women could benefit?","volume":"372","author":"Gorman","year":"2015","journal-title":"N Engl J Med"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-018-00674-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-00674-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923010231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-018-00674-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T19:46:10Z","timestamp":1728675970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923010231"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1878747923010231"],"URL":"https:\/\/doi.org\/10.1007\/s13311-018-00674-4","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and Treatment of Mitochondrial Myopathies","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-018-00674-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 The authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}